EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

What we do

Subscribe to
our newsletter!

AGM 2017 Agenda

Friday, 7th July

15:00-15:15	Welcome and introductions Hans Scheurer, President of MPE Ananda Plate, CEO of MPE
15:15-15:45	Driving through the conference Hans Scheurer, President of MPE Alfonso Aguarón, Project Manager of MPE
15:45-17:00	MPE dialogues: “Where are we now in myeloma and how does the future look like?” Dr. Albert Oriol, Hematology Department, Institut Català d’Oncologia, Spain Sofia Sá Cardoso, Director of Portuguese Association Against Leukaemia (APCL) Susanna Leto, former Patient Advocacy Director of Novartis Oncology Europe Jaime Espín, PhD Professor in the Andalusian School of Public Health Dr Beatriz Flores, Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency (MHRA), UK
17:00-17:15	Coffee break
17:15-18:30	Atlas update Ananda Plate, CEO of MPE Kristina Modic, Director of L&L Slovenia Lucica Nitu, President of SOS Mielom Romania
19:00-20:30	Dinner

Saturday, 8th July

09:00 – 10:00	Update on current diagnosis and treatment of myeloma and related diseases Dr. Sonja Zweegman, VU University Medical Center of Amsterdam, Netherlands
10:00-10:15	Coffee break
10:15-11:15	BREAKOUT SESSIONS
	AL amyloidosis Dr. Giampaolo Merlini, Scientific Institute Policlinico San Matteo, University of Pavia, Italy		Stem cell transplant in myeloma Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
11:15 – 11:30	Coffee break
11:30 – 12:30	BREAKOUT SESSION
	Clinical trials and drugs under development in myeloma & AL amyloidosis Dr. Laurent Garderet, Saint-Antoine Hospital of Paris, France	Panel on myeloma treatment in the light of access barriers Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
12:30 – 14:00	Lunch
14:00 – 16:15	ROTATING SESSIONS (45 minutes each – Choose 3 out of 4) Cross Border Healthcare Ananda Plate, CEO of Myeloma Patients Europe Psychosocial -best practices in supporting patients and carers through the patient journey Ibolya Keri, President of the Foundation for Hungarian Onco-haematological Patients Drug approval route Kate Morgan, Policy and Public Affairs Manager at Myeloma UK Engaging with industry Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group
16:15 – 16:45	Coffee break
16:45 – 17:45	Patient advocate development strategies. How can an umbrella organisation help you? · MPE Advocate Development Programme update Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group Ananda Plate, CEO of MPE Lucica Nitu, President of SOS Mielom Romania
19:00 – 21:00	Off-site dinner

Sunday, 9th July

9:00 – 13:00	Annual General Meeting (Agenda to be defined)
13:00 – 14:00	Farewell lunch

Web Links